Ayah Abdeldayem is a fifth year PhD student at the University of Toronto working under the supervision of Patrick Gunning. Her PhD work focuses on the development of novel, covalent, tunable warheads to address some of the current intractable drug targets in the field of chemical biology and medicinal chemistry. Over the past two years, she has had the opportunity to help develop this technology both academically and in industry, with the resulting platform now translated into the biotech start-up Dunad Therapeutics. She was also involved as a business intern in the early days of Dalriada Drug Discovery where she conducted market analysis, participated in pitch competitions, and got to connect with several incubator hubs across the GTA. Outside of the lab, she is an active member of the Canadian Science Policy Network here in Canada and is passionate about translational technologies and the integration of science into policy making. She is also an avid runner and ran competitively throughout both her undergraduate and PhD years.